Sign inGet started

Winslow Garrett

Insider CIK 1803773 · SBPH General Counsel and Secretary · GLTO General Counsel

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
DMRA Damora Therapeutics, Inc. S Sale2026-07-062026-07-07245$29.98 $7.3K2,289SEC↗
DMRA Damora Therapeutics, Inc. M Exercise deriv2026-07-032026-07-07680— $0640SEC↗
DMRA Damora Therapeutics, Inc. M Exercise2026-07-032026-07-07680— $02,534SEC↗
DMRA Damora Therapeutics, Inc. A Award deriv2026-03-232026-03-25250,000— $0250,000SEC↗
GLTO Galecto, Inc. M Exercise deriv2026-01-022026-01-06680— $01,320SEC↗
GLTO Galecto, Inc. M Exercise2026-01-022026-01-06680— $02,109SEC↗
GLTO Galecto, Inc. S Sale2026-01-022026-01-06255$21.38 $5.5K1,854SEC↗
GLTO Galecto, Inc. M Exercise deriv2025-07-032025-07-08680— $02,000SEC↗
GLTO Galecto, Inc. S Sale2025-07-032025-07-08260$3.39 $8811,429SEC↗
GLTO Galecto, Inc. M Exercise2025-07-032025-07-08680— $01,689SEC↗
GLTO Galecto, Inc. A Award deriv2025-01-032025-01-076,000— $06,000SEC↗
GLTO Galecto, Inc. M Exercise deriv2025-01-032025-01-071,320— $02,680SEC↗
GLTO Galecto, Inc. S Sale2025-01-032025-01-07471$5.60 $2.6K1,009SEC↗
GLTO Galecto, Inc. M Exercise2025-01-032025-01-071,320— $01,480SEC↗
GLTO Galecto, Inc. A Award deriv2024-10-092024-10-1115,600— $015,600SEC↗
GLTO Galecto, Inc. A Award deriv2024-01-032024-01-05100,000— $0100,000SEC↗
GLTO Galecto, Inc. A Award deriv2023-01-042023-01-0580,000— $080,000SEC↗
GLTO Galecto, Inc. A Award deriv2022-01-042022-01-0675,000— $075,000SEC↗
GLTO Galecto, Inc. P Buy2021-12-032021-12-062,000$2.48 $5.0K4,000SEC↗
GLTO Galecto, Inc. P Buy2021-06-232021-06-232,000$4.80 $9.6K2,000SEC↗
GLTO Galecto, Inc. A Award deriv2021-06-152021-06-16120,000— $0120,000SEC↗
SBPH F-star Therapeutics, Inc. S Sale2020-11-202020-11-23175$4.76 $83318,575SEC↗
SBPH F-star Therapeutics, Inc. M Exercise deriv2020-11-192020-11-236,250— $00SEC↗
SBPH F-star Therapeutics, Inc. A Award2020-11-192020-11-2312,500— $018,750SEC↗
SBPH F-star Therapeutics, Inc. M Exercise2020-11-192020-11-236,250— $06,250SEC↗
SBPH Spring Bank Pharmaceutical A Award deriv2020-03-052020-03-0925,000— $025,000SEC↗
SBPH Spring Bank Pharmaceutical A Award deriv2020-03-052020-03-0925,000— $025,000SEC↗